A study found no significant differences in the risk for PsA among patients with psoriasis treated with interleukin (IL)-23 inhibitors and those treated with IL-12/23 inhibitors.
In propensity matched cohorts, the risk for PsA was not statistically different among patients treated with an IL-23 inhibitor and those treated with an IL-12/23 inhibitor , with the IL-23 inhibitor–treated cohort showing marginally higher rates between years 3 and 5.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Psoriatic Arthritis Arthropathic Psoriasis Psoriatic Arthropathy Psa Arthritis Joint Inflammation Interleukins Artificial Intelligence Deep Learning AI NPL Machine Learning ML Natural Language Processing Artificial Neural Networks Biologic Therapy Biologics Hospitals Healthcare And Medical Technology Health And Medical Tech Health And Med Tech
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
MACE Risk Similar Across Biologic Classes Used to Treat Psoriasis, Psoriatic ArthritisA retrospective analysis shows no difference in major adverse cardiovascular events (MACE) between TNF inhibitors, IL-17 inhibitors, IL-23 inhibitors, and IL-12/IL-23 inhibitors.
Les mer »
Dermatologists vs Rheumatologists: Who Should Handle Musculoskeletal Symptoms in Psoriasis?A dermatologist argues for a role to prevent psoriatic arthritis, but rheumatologist favors experience in diagnosis.
Les mer »
Factors Associated With Treatment Failure in Psoriatic ArthritisComorbidities, disease characteristics, and socioeconomic factors were linked to failure to respond to disease-modifying antirheumatic drugs in patients with psoriatic arthritis.
Les mer »
Difficult-to-Treat Rheumatoid Arthritis Resolved in 45% Through Additional Treatment ChangesA new study showed that continued treatment modifications made over a 5-year period could help to resolve difficult-to-treat rheumatoid arthritis.
Les mer »
Arthritis drugs may relieve long COVID lung symptomsResearchers have identified a potential treatment for the respiratory symptoms of long COVID after discovering an unknown cause of the condition inside the lungs.
Les mer »
Pet Owners Reveal The Most Problem-Solving Thing They've Ever PurchasedIncluding a famous robot litter box and a lifesaver leash for dog-walkers with arthritis.
Les mer »